Nextrials is the pioneering force behind Prism, a comprehensive eClinical solution for clinical research. Founded in 2000, Nextrials developed Prism to provide broad support for clinical research, and in 2016 it was acquired by PRA Health Sciences to create a unified clinical software solution. Prism has an impressive track record, having been used by over 50 sponsors, at more than 2,300 sites, and on over 140 studies across nearly 40 countries.

From 3-month studies to those lasting over 7 years, Prism has proven its adaptability in all phases of clinical research, with a primary focus on oncology studies. With a diverse range of indications, Prism offers a powerful solution for biopharmaceutical companies as well as medical device and diagnostic companies. Discover how Prism's eClinical Solution can transform your clinical research.

Contact Nextrials today